Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monsel's solution: a potential vector for nosocomial infection?

Mark E Rupp1, Sharon J Medcalf, Paul D Fey

  • 1University of Nebraska Medical Center, Omaha 68198-4031, USA.

Infection Control and Hospital Epidemiology
|February 27, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practical vs Recent Clinical Trial Use Of Dalbavancin.

JAMA network open·2026
Same author

Two case reports on the identification and management of hypervirulent <i>Klebsiella pneumoniae</i> isolated in Nebraska, USA.

ASM case reports·2026
Same author

Surveillance and Prevention of Vascular Catheter-Associated Infections.

Infectious disease clinics of North America·2026
Same author

Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil.

Open forum infectious diseases·2026
Same author

Not everyone is special: evaluation of indication in a urinalysis-driven reflex urine culture protocol at an academic medical center.

Infection control and hospital epidemiology·2026
Same author

Dr. Mark Rupp: There is a great deal of beauty and goodness in the world, you just have to open your eyes to see it.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026

Monsel's solution, a topical hemostatic agent, is commonly used in surgery. Despite concerns about infection transmission, studies show it inhibits microbial growth, making it unlikely to spread hospital-acquired infections.

Area of Science:

  • Dermatology
  • Gynecology
  • Microbiology

Background:

  • Monsel's solution is a widely used topical hemostatic agent in dermatologic and gynecologic procedures.
  • Concerns exist regarding its potential as a vector for infection transmission due to prolonged storage and multi-patient use.

Purpose of the Study:

  • To evaluate the potential of Monsel's solution to transmit infections in clinical settings.
  • To assess the antimicrobial properties of Monsel's solution.

Main Methods:

  • Microbiologic inoculation studies were performed.
  • Contamination surveys of the solution were conducted.

Main Results:

  • Monsel's solution demonstrated properties that effectively prohibit microbial growth.

Related Experiment Videos

  • Inoculation studies and surveys indicated a low risk of microbial contamination.

    • Conclusions:

    • Monsel's solution is unlikely to serve as a vector for nosocomial infections.
    • Its inherent antimicrobial properties ensure patient safety despite common usage protocols.